One-pot synthesis of isoxazolines and isoxazoles using soluble polymer-supported aldehyde

Journal of Chemical Research

Volumn , Issue 5, 2004, Pages 336-338

  Shang, Yongjia ^a,b   Yuan, Lili ^a   Wang, Yanguang ^b  

^a ANHUI NORMAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

1,3 dipolar cycloaddition; Isoxazol(in)es; Liquid phase synthesis

Indexed keywords

ALDEHYDE; ISOXAZOLE DERIVATIVE; ISOXAZOLINE DERIVATIVE; NITRILE; POLYMER;

ARTICLE; CYCLOADDITION; DIPOLE; LIQUID; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM YIELD; REACTION ANALYSIS; SYNTHESIS;

EID: 3142546855     PISSN: 03082342     EISSN: None     Source Type: Journal    
DOI: 10.3184/0308234041639755     Document Type: Article

References (20)

1. (a) L.A. Thompson and J.A. Ellman, Chem. Rev., 1996, 96, 555;
2. (b) R.E. Dolle, J. Comb. Chem., 2001, 3, 477.
3. H. Han, M.M. Wolfe, S. Brenner and K.D. Janda, Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 6419.
4. (a) J. Wentworth and K.D. Janda, Chem. Commun., 1999, 1917;
5. (b) K.E. Geekeler, Adv. Polym. Sci. 1995, 121, 31.
6. Reviews on liquid-phase organic synthesis (LPOS): (a) D.J. Gravert and K.D. Janda, Chem. Rev. 1997, 97, 489;
7. (b) C.W. Harwig, D.J. Gravert and K.D. Janda, Chemtracts: Org. Chem. 1999, 12, 1;
8. (c) D.J. Gravert and K.D. Janda, In Molecular Diversity and Combinatorial Synthesis: Libraries and Drug Discovery; I.M. Chaiken and K.D. Janda, eds, ACS Symp. Ser.; American Chemical Society: Washington, D C, 1996; 118;
9. (d) A.M. Vandersteen, H. Han and K.D. Janda, Mol. Diversity 1996, 2, 89;
10. (e) R. Annunziata, M. Benaglia, M. Cinquini and F. Cozzi, Chem. Eur. J. 2000, 6, 133.
11. X.Y. Zhao, W.A. Metz, F. Sieber and K.D. Janda, Tetrahedron Lett. 1998, 39, 8433.
12. J. Zhu and L.S. Hegedus, J. Org. Chem. 1995, 60, 5831.
13. M.A. Blaskovich and M. Kahn, J. Org. Chem. 1998, 63, 1119.
14. A search in MDDR (MDL data base) revealed the presence of more than 250 structures based on the isoxazole scaffold and endowed with several pharmacological activities used for analgesia, inflammation, immunology and CNS diseases (such as anxiety, memory impairment, depression, Parkinson's and stroke).
15. For the first example of a liquid-phase 1,3-dipolar cycloaddition reaction see M. Moore and P. Norris, Tetrahedron Lett. 1998, 39, 7027.
16. (a) B.B. Shankar, D.Y. Yang, S. Girton and A.K. Ganguly, Tetrahedron Lett. 1998, 39, 2447;
17. (b) S. Batra, S.K. Rastogi, B. Kundu, A. Patra and A.P. Bhaduri, Tetrahedron Lett. 2000, 41, 5971.
18. L.D. Luca, G. Giacomelli and A. Riu, J. Org. Chem. 2001, 66, 6823.
19. (a) Y.J. Shang, Y.G. Wang, Tetrahedron Lett. 2002, 43, 2247;
20. (b) Y.J. Shang and Y.G. Wang, Synthesis. 2002, 12, 1663.